Patent intelligence · US
US 8458818
Elastomeric gloves and methods of making
Elastomeric gloves and methods of making
Patent details — US 8458818
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 11, 2013
- Expiration
- Jun 6, 2033
- Applicant
- Sentinal Engineering (M) SDN BHD
- Claims
- 15
- CPC classes
- A61K, A61K31/716, A61K36/899
Quick answer
US 8458818 (Elastomeric gloves and methods of making) is held by Sentinal Engineering (M) SDN BHD. Status: granted. Granted Jun 11, 2013. Expires Jun 6, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sentinal Engineering (M) SDN BHD
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K31/716, A61K36/899
More from Sentinal Engineering (M) SDN BHD
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 8458818?
US 8458818 (Elastomeric gloves and methods of making) is held by Sentinal Engineering (M) SDN BHD. Status: granted. Granted Jun 11, 2013. Expires Jun 6, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8458818?
Sentinal Engineering (M) SDN BHD is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 8458818 expire?
Our index shows an expiration date of Jun 6, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.